United Community Banks has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six ...

After a manufacturing-related complete response letter held up the U.S. launch of UCB’s psoriasis med bimekizumab last May, the FDA has officially closed out its inspection of the company's plant in ...

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is ...

Some investors may be wondering if United Community Banks is still a fair deal at around US$34.56 per share, or if the market is missing something in the current price. The stock has recently shown ...

UCB launched Make HStory, a patient-focused educational campaign to raise awareness of hidradenitis suppurativa (HS), a chronic, inflammatory skin condition. The marketing effort unveiled Wednesday ...

How do high-priced mergers and acquisitions get done in the biopharmaceutical industry? In filing a 14D-9 with the Securities and Exchange Commission (SEC), Zogenix of California provided an ...

Belgian drugmaker UCB has agreed to pay $1.9 billion to acquire Zogenix, a company whose flagship drug is commercialized for one particular rare type of epilepsy and holds potential as a treatment for ...

- UCB to have world-wide rights to Staccato® Alprazolam and would perform further clinical development, submission, launch and commercialization of Staccato® Alprazolam - Initial upfront payment of ...

UCB Hell’s Kitchen in New York. Photo: Rafael Rautha/Upright Citizens Brigade Throughout it all, UCB leadership and its founders (Amy Poehler, Matt Besser, Ian Roberts, and Matt Walsh, a.k.a. “the UCB ...